BioSpace News Archive

Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, announces an hour-long webinar to be held today, October 14 at 1 p.m. Eastern time featuring case studies presented by leading neuro-oncologists who have used the company’s CNSide assay in the management of patients with confirmed or suspected central nervous system metastasis.

DiaCarta, Ltd., a precision molecular diagnostics company and developer of novel oncology and infectious disease tests, and HH&L Acquisition Co., a publicly traded special purpose acquisition company, announced that they entered into a definitive business combination agreement that is expected to result in DiaCarta becoming a publicly listed company.

Critical Path Institute (C-Path) announced October 13, 2022 that its Transplant Therapeutic Consortium (TTC), of which Veloxis Pharmaceuticals is a member, received a draft qualification opinion for the iBox Scoring System through the European Medicines Agency’s (EMA) qualification of novel methodologies for drug development.

NuGen Medical Devices Inc., a leader in needle-free drug delivery, is pleased to announce the appointment of Erik Emerson to the Company’s Advisory Board.

T2 Biosystems, Inc., a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced the publication of three new, peer-reviewed studies that demonstrate the clinical value of the use of the T2 Biosystems’ products, also referred to as T2 Magnetic Resonance Technology.

Salarius Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing medicines for patients fighting cancer and in need of new treatment options, announced that it will effect a 1-for-25 reverse stock split at 5:00 p.m. Eastern time.

-Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that its CLIA/CAP-certified clinical laboratory Provista Diagnostics has filed an Emergency Use Authorization (EUA) application with the US Food & Drug Administration (FDA) for its PCR MonkeyPox Test.

Altasciences hired two expert advisors to support its strategic growth in Europe, while its preclinical team continues to expand with the addition of two key employees.

Evolent Health, Inc. (NYSE: EVH) today announced it will release its third quarter 2022 operating results on Wednesday, November 2, 2022 after market close, with a conference call to follow at 5:00 p.m. Eastern Time.

Pacylex today announced that the U.S. Food and Drug Administration (FDA) granted PCLX-001 Orphan Drug Designation for “treatment of patients with acute myeloid leukemia.”